Big Move: Eli Lilly Offers Obesity Drug Directly to Consumers
Jan. 5, 2024 — Eli Lilly, maker of the anti-obesity drug Zepbound, announced this week the launch of LillyDirect, a direct-to-patient portal, allowing some patients… Read More »Big Move: Eli Lilly Offers Obesity Drug Directly to Consumers

